Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008

International Journal of Drug Policy

Volumn 21, Issue 6, 2010, Pages 471-476

  Iversen, Jenny ^a   Wand, Handan ^a   Gonnermann, Andrea ^b   Maher, Lisa ^a,c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF BREMEN   (Germany)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gender; Hepatitis C virus (HCV); Injection drug use (IDU)

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; HEPATITIS C ANTIBODY; METHADONE;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; AUSTRALIA; CAPILLARY BLOOD; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HARM REDUCTION; HEALTH SURVEY; HEPATITIS C; HIGH RISK BEHAVIOR; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIGENOUS PEOPLE; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NEEDLE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SYRINGE;

ADOLESCENT; ADULT; AGED; AUSTRALIA; CROSS-SECTIONAL STUDIES; FEMALE; HARM REDUCTION; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; MIDDLE AGED; NEEDLE SHARING; OCEANIC ANCESTRY GROUP; PREVALENCE; QUESTIONNAIRES; RISK-TAKING; SEX FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS; YOUNG ADULT;

EID: 78649324045     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.04.004     Document Type: Article

References (45)

1. Alter M.J., Moyer L.A. The importance of preventing hepatitis C virus infection among injection drug users in the United States. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 1998, 18(Suppl. 1):S6-10.
2. Bourgois P., Prince B., Moss A. The everyday violence of hepatitis C among young women who inject drugs in San Francisco. Human Organization 2004, 63(3):253-264.
3. Brown K., Crofts N. Health care costs of a continuing epidemic of hepatitis C virus infection among injecting drug users. Australian and New Zealand Journal of Public Health 1998, 22(3 Suppl.):384-388.
4. Butler T., Spencer J., Cui J., Vickery K., Zou J., Kaldor J. Seroprevalence of markers for hepatitis B, C and G in male and female prisoners-NSW, 1996. Australian and New Zealand Journal of Public Health 1999, 23(4):377-384.
5. Choi Y., Harachi T.W., Catalano R.F. Neighborhoods, family, and substance use: Comparisons of the relations across racial and ethnic groups. Social Service Review 2006, 80(4):675-704.
6. Crofts N., Louie R., Rosenthal D., Jolley D. The first hit: Circumstances surrounding initiation into injecting. Addiction 1996, 91(8):1187-1196.
7. Crofts N., Stewart T., Hearne P., Ping X.Y., Breshkin A.M., Locarnini S.A. Spread of bloodborne viruses among Australian prison entrants. BMJ 1995, 310(6975):285-288.
8. Cruz M.F., Mantsios A., Ramos R., Case P., Brouwer K.C., Ramos M.E., et al. A qualitative exploration of gender in the context of injection drug use in two US-Mexico border cities. AIDS Behaviour 2007, 11(2):253-262.
9. Davies A.G., Dominy N.J., Peters A.D., Richardson A.M. Gender differences in HIV risk behaviour of injecting drug users in Edinburgh. AIDS Care 1996, 8(5):517-527.
10. Day C.A., Topp L., Iversen J., Maher L. Blood-borne virus prevalence and risk among steroid injectors: Results from the Australian Needle and Syringe Program Survey. Drug and Alcohol Review 2008, 27(5):559-561.
11. Dore G.J., Law M., MacDonald M., Kaldor J.M. Epidemiology of hepatitis C virus infection in Australia. Journal of Clinical Virology 2003, 26(2):171-184.
12. Evans J.L., Hahn J.A., Page-Shafer K., Lum P.J., Stein E.S., Davidson P.J., et al. Gender differences in sexual and injection risk behavior among active young injection drug users in San Francisco (the UFO Study). Journal of Urban Health 2003, 80(1):137-146.
13. Frajzyngier V., Neaigus A., Gyarmathy V.A., Miller M., Friedman S.R. Gender differences in injection risk behaviors at the first injection episode. Drug and Alcohol Dependence 2007, 89(2-3):145-152.
14. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome Human Retrovirology 1998, 18(Suppl. 1):S11-19.
15. Grebely J., Raffa J.D., Lai C., Krajden M., Conway B., Tyndall M.W. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. Canadian Journal of Gastroenterology 2007, 21(7):447-451.
16. Guy R.J., McDonald A.M., Bartlett M.J., Murray J.C., Giele C.M., Davey T.M., et al. HIV diagnoses in Australia: Diverging epidemics within a low-prevalence country. Medical Journal of Australia 2007, 187(8):437-440.
17. Hagan H., Des Jarlais D.C., Stern R., Lelutiu-Weinberger C., Scheinmann R., Strauss S., et al. HCV synthesis project: Preliminary analyses of HCV prevalence in relation to age and duration of injection. International Journal of Drug Policy 2007, 18(5):341-351.
18. Hagan H., Thiede H., Des Jarlais D.C. Hepatitis C virus infection among injection drug users: Survival analysis of time to seroconversion. Epidemiology 2004, 15(5):543-549.
19. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. American Journal of Public Health 2001, 91(1):42-46.
20. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., et al. Hepatitis C virus seroconversion among young injection drug users: Relationships and risks. Journal of Infectious Disease 2002, 186(11):1558-1564.
21. Latkin C.A., Hua W., Forman V.L. The relationship between social network characteristics and exchanging sex for drugs or money among drug users in Baltimore, MD, USA. International Journal of STD AIDS 2003, 14(11):770-775.
22. Lidman C., Norden L., Kaberg M., Kall K., Franck J., Aleman S., et al. Hepatitis C infection among injection drug users in Stockholm Sweden: Prevalence and gender. Scandinavian Journal of Infectious Disease 2009, 1-6.
23. MacDonald M., Crofts N., Kaldor J. Transmission of hepatitis C virus: Rates, routes, and cofactors. Epidemiological Review 1996, 18(2):137-148.
24. MacDonald M., Wodak A.D., Ali R., Crofts N., Cunningham P.H., Dolan K.A., et al. HIV prevalence and risk behaviour in needle exchange attenders: A national study. The Collaboration of Australian Needle Exchanges. Medical Journal of Australia 1997, 166(5):237-240.
25. MacDonald M.A., Wodak A.D., Dolan K.A., van Beek I., Cunningham P.H., Kaldor J.M. Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997. Collaboration of Australian NSPs. Medical Journal of Australia 2000, 172(2):57-61.
26. MacRae R., Aalto E. Gendered power dynamics and HIV risk in drug-using sexual relationships. AIDS Care 2000, 12(4):505-515.
27. Maher L. Sexed work: Gender, race, and resistance in a Brooklyn drug market 1997, Clarendon Press, Oxford.
28. Maher L., Li J., Jalaludin B., Chant K.G., Kaldor J.M. High hepatitis C incidence in new injecting drug users: A policy failure?. Australian and New Zealand Journal of Public Health 2007, 31(1):30-35.
29. Micallef J.M., Kaldor J.M., Dore G.J. Spontaneous viral clearance following acute hepatitis C infection: A systematic review of longitudinal studies. Journal of Viral Hepatitis 2006, 13(1):34-41.
30. Ministerial Advisory Committee on AIDS Sexual Health and Hepatitis Hepatitis C virus projections working group: Estimates and projections of the Hepatitis C virus epidemic in Australia 2006 2006, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Sydney.
31. Montgomery S.B., Hyde J., De Rosa C.J., Rohrbach L.A., Ennett S., Harvey S.M., et al. Gender differences in HIV risk behaviors among young injectors and their social network members. American Journal of Drug Alcohol and Abuse 2002, 28(3):453-475.
32. Nagasue N., Kohno H. Hepatocellular carcinoma and sex hormones. HPB Surgery 1992, 6(1):1-6.
33. National Centre in HIV Epidemiology and Clinical Research Australian NSP Survey National Data Report 1995-2002 2003, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney.
34. National Centre in HIV Epidemiology and Clinical Research HIV/AIDS, viral hepatitis and sexually transmissible infections in Australia Annual Surveillance Report 2008 2008, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Sydney.
35. National Centre in HIV Epidemiology and Clinical Research Australian NSP Survey National Data Report 2004-2008 2009, National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, NSW, Sydney.
36. Page K., Hahn J.A., Evans J., Shiboski S., Lum P., Delwart E., et al. Acute hepatitis C virus infection in young adult injection drug users: A prospective study of incident infection, resolution, and reinfection. Journal of Infectious Disease 2009, 200(8):1216-1226.
37. Rhodes T., Quirk A. Drug users' sexual relationships and the social organisation of risk: The sexual relationship as a site of risk management. Social Service Review 1998, 46(2):157-169.
38. Sherman S.G., Latkin C.A., Gielen A.C. Social factors related to syringe sharing among injecting partners: A focus on gender. Substance Use and Misuse 2001, 36(14):2113-2136.
39. Stafford J., Sindicich N., Burns L., Cassar J., Cogger S., de Graaff B., et al. Australian drug trends 2008: Findings from the illicit drug reporting system (IDRS) 2008, National Drug and Alcohol Research Centre, University of New South Wales, Sydney.
40. Strathdee S.A., Lozada R., Pollini R.A., Brouwer K.C., Mantsios A., Abramovitz D.A., et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. Journal of Acquired Immune Deficiency Syndrome 2008, 47(3):369-376.
41. Sy T., Jamal M.M. Epidemiology of hepatitis C virus (HCV) infection. International Journal of Medical Science 2006, 3(2):41-46.
42. Topp L., Iversen J., Wand H., Day C., Kaldor J., Maher L. Representativeness of injecting drug users who participate in HIV surveillance: Results from Australia's Needle and Syringe Program Survey. Journal of Acquired Immune Deficiency Syndrome 2008, 47(5):632-638.
43. Unger J., Kipke M.D., De Rosa C.J., Hyde J., Ritt-Olsen A., Montgomery S.B. Needle-sharing among young IV drug users and their social network members: The influence of the injection partner's characteristics on HIV risk behavior. Addictive Behaviors 2006, 31(9):1607-1618.
44. Villano S.A., Vlahov D., Nelson K.E., Lyles C.M., Cohn S., Thomas D.L. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. Journal of Clinical Microbiology 1997, 35(12):3274-3277.
45. Wands J. Hepatocellular carcinoma and sex. New England Journal of Medicine 2007, 357(19):1974-1976.